PL98610B1 - Sposob jednoczesnego otrzymywania insuliny i pankreaktyny z trzustki swin - Google Patents
Sposob jednoczesnego otrzymywania insuliny i pankreaktyny z trzustki swin Download PDFInfo
- Publication number
- PL98610B1 PL98610B1 PL1975185730A PL18573075A PL98610B1 PL 98610 B1 PL98610 B1 PL 98610B1 PL 1975185730 A PL1975185730 A PL 1975185730A PL 18573075 A PL18573075 A PL 18573075A PL 98610 B1 PL98610 B1 PL 98610B1
- Authority
- PL
- Poland
- Prior art keywords
- extraction
- insulin
- acetone
- mixture
- extract
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims description 61
- 102000004877 Insulin Human genes 0.000 title claims description 31
- 108090001061 Insulin Proteins 0.000 title claims description 31
- 229940125396 insulin Drugs 0.000 title claims description 31
- 238000000034 method Methods 0.000 title claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 42
- 238000000605 extraction Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 11
- 210000000496 pancreas Anatomy 0.000 claims description 10
- 108010019160 Pancreatin Proteins 0.000 claims description 9
- 210000004907 gland Anatomy 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 229940055695 pancreatin Drugs 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 241000282887 Suidae Species 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 3
- 150000007519 polyprotic acids Polymers 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229960003624 creatine Drugs 0.000 claims description 2
- 239000006046 creatine Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 159000000007 calcium salts Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229960002376 chymotrypsin Drugs 0.000 description 3
- -1 hydrogen ions Chemical class 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000337 buffer salt Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000353790 Doru Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- UCUJUFDOQOJLBE-UHFFFAOYSA-N [Cl].[Ca] Chemical compound [Cl].[Ca] UCUJUFDOQOJLBE-UHFFFAOYSA-N 0.000 description 1
- AAELHWDCDSZXGG-UHFFFAOYSA-L [Na+].[Cl+].[Cl-].[Cl-] Chemical compound [Na+].[Cl+].[Cl-].[Cl-] AAELHWDCDSZXGG-UHFFFAOYSA-L 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- IBIRZFNPWYRWOG-UHFFFAOYSA-N phosphane;phosphoric acid Chemical compound P.OP(O)(O)=O IBIRZFNPWYRWOG-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/94—Pancreatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/843—Digestive system
- Y10S530/845—Pancreas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2460334A DE2460334C3 (de) | 1974-12-20 | 1974-12-20 | Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL98610B1 true PL98610B1 (pl) | 1978-05-31 |
Family
ID=5933942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1975185730A PL98610B1 (pl) | 1974-12-20 | 1975-12-19 | Sposob jednoczesnego otrzymywania insuliny i pankreaktyny z trzustki swin |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4029641A (en, 2012) |
| JP (1) | JPS5186113A (en, 2012) |
| AR (1) | AR208214A1 (en, 2012) |
| AT (1) | AT341078B (en, 2012) |
| BE (1) | BE836952A (en, 2012) |
| BG (1) | BG39801A3 (en, 2012) |
| BR (1) | BR7508415A (en, 2012) |
| CA (1) | CA1057683A (en, 2012) |
| CH (1) | CH628322A5 (en, 2012) |
| CS (1) | CS214870B2 (en, 2012) |
| DD (1) | DD123455A5 (en, 2012) |
| DE (1) | DE2460334C3 (en, 2012) |
| DK (1) | DK141666C (en, 2012) |
| ES (1) | ES443499A1 (en, 2012) |
| FR (1) | FR2295016A1 (en, 2012) |
| GB (1) | GB1536700A (en, 2012) |
| HK (1) | HK39880A (en, 2012) |
| HU (1) | HU176799B (en, 2012) |
| IE (1) | IE42224B1 (en, 2012) |
| IT (1) | IT1051388B (en, 2012) |
| LU (1) | LU74045A1 (en, 2012) |
| NL (1) | NL170804C (en, 2012) |
| NO (1) | NO144040C (en, 2012) |
| NZ (1) | NZ179582A (en, 2012) |
| PL (1) | PL98610B1 (en, 2012) |
| RO (1) | RO66021A (en, 2012) |
| SE (1) | SE436541B (en, 2012) |
| SU (1) | SU651656A3 (en, 2012) |
| YU (1) | YU40130B (en, 2012) |
| ZA (1) | ZA757871B (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2119248A (en) * | 1982-04-28 | 1983-11-16 | John Kenneth Mcmullen | Insulin formulations and method of producing them |
| JPS58175322U (ja) * | 1982-05-12 | 1983-11-24 | 株式会社トヨトミ | 石油ガス化バ−ナ |
| CA2198317C (en) * | 1997-02-24 | 2003-01-07 | Mouhsine El Abboudi | Method for preparing pancreatin which contains low amounts of residual organic solvent and product thereof |
| US7153504B2 (en) * | 2004-07-30 | 2006-12-26 | Can Technologies, Inc. | Stabilized pancreas product |
| AU2011309763B2 (en) | 2010-10-01 | 2015-08-13 | Allergan Therapeutics LLC | Enteric coated, low- strength pancrelipase formulations |
| CN106163544A (zh) | 2013-08-09 | 2016-11-23 | 阿勒根制药国际有限公司 | 适于经肠施用的消化酶组合物 |
| MX2016000480A (es) * | 2013-11-05 | 2016-10-21 | Allergan Pharmaceuticals Int Ltd | Composiciones farmaceuticas de pancreatina de alta potencia. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2466487A (en) * | 1946-07-24 | 1949-04-05 | Univ Alberta | Process of obtaining insulin from pancreas glands |
| US2573099A (en) * | 1946-10-23 | 1951-10-30 | Novo Terapeutisk Labor As | Method of recovering proteolytic enzymes from mammalian pancreas glands with urea |
| US2779706A (en) * | 1950-08-12 | 1957-01-29 | Organon | Insulin extraction |
| US2752286A (en) * | 1952-09-11 | 1956-06-26 | Armour & Co | Extraction of insulin from pancreas tissue |
| US2897117A (en) * | 1955-02-10 | 1959-07-28 | Univ Alberta | Insulin process |
| NL6816599A (en, 2012) * | 1968-11-20 | 1970-05-22 |
-
1974
- 1974-12-20 DE DE2460334A patent/DE2460334C3/de not_active Expired
-
1975
- 1975-01-01 AR AR261680A patent/AR208214A1/es active
- 1975-12-15 ES ES443499A patent/ES443499A1/es not_active Expired
- 1975-12-15 NL NLAANVRAGE7514576,A patent/NL170804C/xx not_active IP Right Cessation
- 1975-12-16 BG BG031806A patent/BG39801A3/xx unknown
- 1975-12-16 RO RO7584224A patent/RO66021A/ro unknown
- 1975-12-17 SU SU752301056A patent/SU651656A3/ru active
- 1975-12-17 HU HU75HO1863A patent/HU176799B/hu unknown
- 1975-12-17 CS CS758639A patent/CS214870B2/cs unknown
- 1975-12-17 CH CH1637475A patent/CH628322A5/de not_active IP Right Cessation
- 1975-12-18 US US05/641,927 patent/US4029641A/en not_active Expired - Lifetime
- 1975-12-18 NZ NZ179582A patent/NZ179582A/xx unknown
- 1975-12-18 DD DD190297A patent/DD123455A5/xx unknown
- 1975-12-18 LU LU74045A patent/LU74045A1/xx unknown
- 1975-12-18 IT IT30480/75A patent/IT1051388B/it active
- 1975-12-18 YU YU3229/75A patent/YU40130B/xx unknown
- 1975-12-18 BR BR7508415*A patent/BR7508415A/pt unknown
- 1975-12-19 NO NO754325A patent/NO144040C/no unknown
- 1975-12-19 DK DK581375A patent/DK141666C/da not_active IP Right Cessation
- 1975-12-19 IE IE2770/75A patent/IE42224B1/en unknown
- 1975-12-19 PL PL1975185730A patent/PL98610B1/pl unknown
- 1975-12-19 ZA ZA757871A patent/ZA757871B/xx unknown
- 1975-12-19 SE SE7514448A patent/SE436541B/xx not_active IP Right Cessation
- 1975-12-19 JP JP50150667A patent/JPS5186113A/ja active Granted
- 1975-12-19 AT AT968675A patent/AT341078B/de not_active IP Right Cessation
- 1975-12-19 CA CA242,359A patent/CA1057683A/en not_active Expired
- 1975-12-19 FR FR7539201A patent/FR2295016A1/fr active Granted
- 1975-12-22 BE BE163015A patent/BE836952A/xx not_active IP Right Cessation
- 1975-12-22 GB GB52458/75A patent/GB1536700A/en not_active Expired
-
1980
- 1980-07-31 HK HK398/80A patent/HK39880A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3969540A (en) | Enzymatically prepared metal proteinates | |
| Rathelot et al. | Studies on the effect of bile salt and colipase on enzymatic lipolysis. Improved method for the determination of pancreatic lipase and colipase | |
| Davenport et al. | A natural factor catalyzing reduction of methaemoglobin by isolated chloroplasts | |
| Irving et al. | Inositol phosphate phosphatases of microbiological origin. Some properties of a partially purified bacterial (Pseudomonas sp.) phytase | |
| US3956483A (en) | Preparing pancreatin | |
| PL98610B1 (pl) | Sposob jednoczesnego otrzymywania insuliny i pankreaktyny z trzustki swin | |
| Myers et al. | Studies on ali-esterases and other lipid-hydrolysing enzymes. 2. The effect of heparin injection on alimentary lipaemia and on the plasma esterases | |
| US3944655A (en) | Process of preparing food products from bones | |
| US3168448A (en) | Process of preparing a lipolytic enzyme composition | |
| US3925158A (en) | Process of manufacturing enzyme preparation rich in lipase | |
| US1892247A (en) | Process of preparing proteinases free from peptidases | |
| Booth | A water-soluble precursor of choline found in the kidney and other tissues | |
| US2489173A (en) | Preparation of whipping composition and the resulting product | |
| US2156790A (en) | Wettable sulphur composition | |
| US2637680A (en) | Method for the extraction of insulin as well as enzymes from pancreas | |
| US2857278A (en) | Production of edible protein products from fish solubles | |
| Finn et al. | Adenylate cyclase system of bovine adrenal plasma membranes. | |
| US2193523A (en) | Vitamin preparation | |
| US3539451A (en) | Production of reversibly inactivated papain and ficin | |
| US2590517A (en) | Method for the preparation of peptone and amino acid containing extracts from press water | |
| US338471A (en) | Moeitz blumenthal | |
| JPH0343233B2 (en, 2012) | ||
| US3306823A (en) | Somatotropic hormone | |
| AT217636B (de) | Verfahren zur Herstellung eines leicht wasserlöslichen Proteinpräparates für die Carcinomdiagnose | |
| Moore et al. | Studies on the Intestinal Absorption and Excretion of Calcium and Phosphorus in the Pig: 3. The Effect of Beryllium Carbonate on the Absorption of Phosphorus |